Findings of Research Misconduct, 71172 [E6-20927]
Download as PDF
<![CDATA[
71172
Federal Register / Vol. 71, No. 236 / Friday, December 8, 2006 / Notices
institution is engaged in human subjects
research.
All of the modifications and
clarifications proposed in OHRP’s draft
guidance document, including those
discussed above, are reflected in the
comparison table of the previous
guidance documents and the new draft
guidance document on OHRP’s Web site
at https://www.hhs.gov/ohrp/requests/.
OHRP welcomes comments on its draft
guidance.
Dated: December 1, 2006.
Melody Lin,
Deputy Director, Office for Human Research
Protections.
[FR Doc. E6–20849 Filed 12–7–06; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
(2) that any institution which submits
an application for PHS support for a
research project on which Mr.
McMaster’s participation is proposed or
which uses him in any capacity on PHS
supported research, or that submits a
report of PHS-funded research in which
he is involved, must concurrently
submit a plan for supervision of his
duties to the funding agency for
approval. The supervisory plan must be
designed to ensure the scientific
integrity of his research contribution.
Mr. McMaster also agrees to ensure that
the institution submits a copy of the
supervisory plan to ORI. He further
agrees that he will not participate in any
PHS-supported research until such a
supervisory plan is submitted to ORI.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
AGENCY:
ACTION:
Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. E6–20927 Filed 12–7–06; 8:45 am]
BILLING CODE 4150–31–P
sroberts on PROD1PC70 with NOTICES
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.
SUMMARY: Notice is hereby given that
the Office of Research Integrity (ORI)
and the Assistant Secretary for Health
have taken final action in the following
case:
Nicholas McMaster, University of
Chicago: Based on a College Discipline
Hearing report and on additional
analysis conducted by ORI in its
oversight review, the U.S. Public Health
Service (PHS) found that Mr. Nicholas
McMaster, undergraduate student,
Biological Sciences Collegiate Division
in the Departments of Psychology and
Comparative Human Development at
the University of Chicago (UC), engaged
in research misconduct supported by
National Institute of Environmental
Health Sciences (NIEHS), National
Institutes of Health (NIH), grant P50
ES12382 and National Institute on
Aging (NIA), NIH, grant P01 AG018911.
Specifically, PHS found that Mr.
McMaster fabricated data in recording
the score for the lordosis reflex and in
recording the cell types present in
vaginal epithelium from rats in two
experimental psychology protocols.
Mr. McMaster has entered into a
Voluntary Exclusion Agreement in
which he has voluntarily agreed, for a
period of three (3) years, beginning on
November 14, 2006:
(1) To exclude himself from serving in
any advisory capacity to PHS, including
but not limited to service on any PHS
advisory committee, board, and/or peer
review committee, or as a consultant;
and
VerDate Aug<31>2005
19:05 Dec 07, 2006
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration on Aging
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Alzheimer’s
Disease Demonstration Grants to
States Program Standardized Data
Collection
Administration on Aging, HHS.
Notice.
AGENCY:
ACTION:
SUMMARY: The Administration on Aging
(AoA) is announcing an opportunity for
public comment on the proposed
collection of certain information by the
agency. Under the Paperwork Reduction
Act of 1995 (the PRA), Federal agencies
are required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection requirements relating to
Alzheimer’s Disease Demonstration
Grants to States Program
DATES: Submit written or electronic
comments on the collection of
information by February 6, 2007.
ADDRESSES: Submit electronic
comments on the collection of
information to:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Lori.Stalbaum@aoa.hhs.gov. Submit
written comments on the collection of
information to Administration on Aging,
Washington, DC 20201, ATTN: Lori
Stalbaum.
FOR FURTHER INFORMATION CONTACT: Lori
Stalbaum at 202–357–3452 or e-mail:
lori.stalbaum@aoa.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency request
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, AoA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following collection
of information, AoA invites comments
on: (1) Whether the proposed collection
of information is necessary for the
proper performance of AoA’s functions,
including whether the information will
have practical utility; (2) the accuracy of
AoA’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
when appropriate, and other forms of
information technology.
The Alzheimer’s Disease
Demonstration Grants to States
(ADDGS) Program is authorized through
Sections 398, 399 and 399A of the
Public Health Service (PHS) Act, as
amended by Public Law 101–557 Home
Health Care and Alzheimer’s Disease
Amendments of 1990. The ADDGS
program funded through AoA helps
states extend family support services
provided by subgrantees to underserved
populations, including those in rural
communities.
The PHS Act requires AoA to
‘‘provide for an evaluation of each
demonstration project for which a grant
is made.’’ The PHS Act further states
E:\FR\FM\08DEN1.SGM
08DEN1
]]>Agencies
[Federal Register Volume 71, Number 236 (Friday, December 8, 2006)]
[Notices]
[Page 71172]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20927]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) and the Assistant Secretary for Health have taken final action in
the following case:
Nicholas McMaster, University of Chicago: Based on a College
Discipline Hearing report and on additional analysis conducted by ORI
in its oversight review, the U.S. Public Health Service (PHS) found
that Mr. Nicholas McMaster, undergraduate student, Biological Sciences
Collegiate Division in the Departments of Psychology and Comparative
Human Development at the University of Chicago (UC), engaged in
research misconduct supported by National Institute of Environmental
Health Sciences (NIEHS), National Institutes of Health (NIH), grant P50
ES12382 and National Institute on Aging (NIA), NIH, grant P01 AG018911.
Specifically, PHS found that Mr. McMaster fabricated data in
recording the score for the lordosis reflex and in recording the cell
types present in vaginal epithelium from rats in two experimental
psychology protocols.
Mr. McMaster has entered into a Voluntary Exclusion Agreement in
which he has voluntarily agreed, for a period of three (3) years,
beginning on November 14, 2006:
(1) To exclude himself from serving in any advisory capacity to
PHS, including but not limited to service on any PHS advisory
committee, board, and/or peer review committee, or as a consultant; and
(2) that any institution which submits an application for PHS
support for a research project on which Mr. McMaster's participation is
proposed or which uses him in any capacity on PHS supported research,
or that submits a report of PHS-funded research in which he is
involved, must concurrently submit a plan for supervision of his duties
to the funding agency for approval. The supervisory plan must be
designed to ensure the scientific integrity of his research
contribution. Mr. McMaster also agrees to ensure that the institution
submits a copy of the supervisory plan to ORI. He further agrees that
he will not participate in any PHS-supported research until such a
supervisory plan is submitted to ORI.
FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite
750, Rockville, MD 20852, (240) 453-8800.
Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. E6-20927 Filed 12-7-06; 8:45 am]
BILLING CODE 4150-31-P
